Literature DB >> 15894381

Comorbid psychiatric disorders in depressed outpatients: demographic and clinical features.

A John Rush1, Mark Zimmerman, Stephen R Wisniewski, Maurizio Fava, Steven D Hollon, Diane Warden, Melanie M Biggs, Kathy Shores-Wilson, Richard C Shelton, James F Luther, Brandi Thomas, Madhukar H Trivedi.   

Abstract

BACKGROUND: This study evaluated the clinical and sociodemographic features associated with various degrees of concurrent comorbidity in adult outpatients with nonpsychotic major depressive disorder (MDD).
METHODS: Outpatients enrolled in the STAR*D trial completed the Psychiatric Diagnostic Screening Questionnaire (PDSQ). An a priori 90% specificity threshold was set for PDSQ responses to ascertain the presence of 11 different concurrent DSM-IV Axis I disorders.
RESULTS: Of 1376 outpatients, 38.2% had no concurrent comorbidities, while 25.6% suffered one, 16.1% suffered two, and 20.2% suffered three or more comorbid conditions. Altogether, 29.3% met threshold for social anxiety disorder, 20.8% for generalized anxiety disorder, 18.8% for posttraumatic stress disorder, 12.4% for bulimia, 11.9% for alcohol abuse/dependence, 13.4% for obsessive-compulsive disorder, 11.1% for panic disorder, 9.4% for agoraphobia, 7.3% for drug abuse/dependence, 3.7% for hypochondriasis, and 2.2% for somatoform disorder. Those with more concurrent Axis I conditions had earlier ages at first onset of MDD, longer histories of MDD, greater depressive symptom severity, more general medical comorbidity (even though they were younger than those with fewer comorbid conditions), poorer physical and mental function, health perceptions, and life satisfaction; and were more likely to be seen in primary care settings. LIMITATIONS: Participants had to meet entry criteria for STAR*D. Ascertainment of comorbid conditions was not based on a structured interview.
CONCLUSIONS: Concurrent Axis I conditions (most often anxiety disorders) are very common with MDD. Greater numbers of concurrent comorbid conditions were associated with increased severity, morbidity, and chronicity of their MDD.

Entities:  

Mesh:

Year:  2005        PMID: 15894381     DOI: 10.1016/j.jad.2005.03.005

Source DB:  PubMed          Journal:  J Affect Disord        ISSN: 0165-0327            Impact factor:   4.839


  52 in total

1.  What are the clinical implications of new onset or worsening anxiety during the first two weeks of SSRI treatment for depression?

Authors:  Jackie K Gollan; Maurizio Fava; Benji Kurian; Stephen R Wisniewski; A John Rush; Ella Daly; Sachiko Miyahara; Madhukar H Trivedi
Journal:  Depress Anxiety       Date:  2011-12-06       Impact factor: 6.505

2.  Temporal patterns of anxious and depressed mood in generalized anxiety disorder: a daily diary study.

Authors:  Lisa R Starr; Joanne Davila
Journal:  Behav Res Ther       Date:  2011-12-07

3.  Assessing anxious features in depressed outpatients.

Authors:  Shawn M McClintock; Mustafa M Husain; Ira H Bernstein; Stephen R Wisniewski; Madhukar H Trivedi; David Morris; Jonathan Alpert; Diane Warden; James F Luther; Susan G Kornstein; Melanie M Biggs; Maurizio Fava; A John Rush
Journal:  Int J Methods Psychiatr Res       Date:  2011-11-04       Impact factor: 4.035

4.  Association between bipolar spectrum features and treatment outcomes in outpatients with major depressive disorder.

Authors:  Roy H Perlis; Rudolf Uher; Michael Ostacher; Joseph F Goldberg; Madhukar H Trivedi; A John Rush; Maurizio Fava
Journal:  Arch Gen Psychiatry       Date:  2010-12-06

5.  Depressive subtype a predictor of cardiovascular morbidity.

Authors:  Meera Narasimhan; Prakash Masand
Journal:  Curr Psychiatry Rep       Date:  2008-06       Impact factor: 5.285

6.  Cognitive therapy for depressed adults with comorbid social phobia.

Authors:  Jasper A J Smits; Abu Minhajuddin; Robin B Jarrett
Journal:  J Affect Disord       Date:  2008-09-18       Impact factor: 4.839

7.  Presence and Predictive Value of Obsessive-Compulsive Symptoms in Anxiety and Depressive Disorders.

Authors:  Mieke Klein Hofmeijer-Sevink; Neeltje M Batelaan; Harold J G M van Megen; Marcel A van den Hout; Brenda W Penninx; Anton J L M van Balkom; Danielle C Cath
Journal:  Can J Psychiatry       Date:  2017-05-16       Impact factor: 4.356

8.  Translating Science Into Service: Lessons Learned From the Sequenced Treatment Alternatives to Relieve Depression (STAR*D) Study.

Authors:  Norman Sussman
Journal:  Prim Care Companion J Clin Psychiatry       Date:  2007

9.  Effects of chronic plus acute prolonged stress on measures of coping style, anxiety, and evoked HPA-axis reactivity.

Authors:  Megan K Roth; Brian Bingham; Aparna Shah; Ankur Joshi; Alan Frazer; Randy Strong; David A Morilak
Journal:  Neuropharmacology       Date:  2012-07-25       Impact factor: 5.250

Review 10.  Public health significance of neuroticism.

Authors:  Benjamin B Lahey
Journal:  Am Psychol       Date:  2009 May-Jun
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.